Orchid Asia Group Management
TPG-backed Dingdang Health raises $51m in Hong Kong IPO
Chinese online pharmacy platform Dingdang Health has raised HKD 402.4m (USD 51m) through a Hong Kong IPO, defying challenging conditions for financial sponsors targeting the bourse.
Boyu stands out in weak quarter for private equity fundraising
A quickfire fundraise by Boyu Capital – which saw $6 billion collected across two pools of capital in the space of a few months – accounted for more than one-quarter of all capital committed to Asia-focused private equity managers between April and...
China online pharmacy Dingdang seeks Hong Kong IPO
Dingdang Health, a Chinese online pharmacy business that raised $220 million in funding earlier this month, has filed for a Hong Kong IPO.
Orchid Asia reaches $1.1b first close on Fund VIII
Orchid Asia has achieved a first close of $1.1 billion on its eighth fund, five months after launching the vehicle with a full target of $1.6 billion.
Orchid, Matrix commit $100m to China gaming platform
Orchid Asia and Matrix Partners China have participated in a $100 million Series B round for Chinese gaming company Quwan Network Technology. Matrix led the Series A last year.
China's Snowball Finance raises $120m
Snowball Finance, a Chinese online financial information platform with wealth management ambitions, has raised $120 million Series E from Orchid Asia.
Orchid, TPG-backed Duiba trades flat on Hong Kong debut
Duiba, operator of a China-based interactive advertising platform and software-as-a-service (SaaS) management system for online businesses, traded flat on its Hong Kong debut, following an IPO of HK$766.2 million($97.6 million).
PE-backed Chinese cosmetic surgery platform surges on US debut
So-Young International, a Chinese online marketplace specializing in cosmetic surgery, surged over 33% on its trading debut following a $166.8 million IPO on NASDAQ.
Chinese cosmetic surgery marketplace files for US IPO
So-Young International, a Chinese online marketplace focusing on cosmetic surgery, has filed to list in the US. PE backers include Orchid Asia, Matrix Partners China, and the Russia-China Investment Fund (RCIF).
Vision Knight backs Chinese personal care products maker
Vision Knight Capital has led a RMB200 million ($29 million) Series C round for Soocas, a Shenzhen-based manufacturer of personal care products such as electric toothbrushes and hairdryers.
Chinese eye hospital chain Chaoju raises $59m
Chinese eye hospital chain operator Chaoju Ophthalmology has raised RMB400 million ($59 million) in a Series B round of funding backed by Orchid Asia Group and River Head Capital.
Tiger Global leads round for China online music tuition business
VIP Peilian, a Chinese online music education platform, has raised $150 million in a Series C round of funding led by Tiger Global Management.
Orchid, TPG-backed Duiba files for Hong Kong IPO
Duiba, a Chinese enterprise services company in which Orchid Asia and TPG Capital recently invested $110 million, has filed for a Hong Kong listing.
Orchid leads $70m Series E for China's SoYoung
SoYoung, a Chinese online marketplace focusing on cosmetic surgery, has raised $70 million in Series E funding led by Orchid Asia. There was additional participation from Matrix Partners China, BOC International, and the Russia-China Investment Fund (RCIF).
Orchid, TPG lead $110m Series C for China's Duiba
Orchid Asia and TPG Capital have led a $110 million Series C round for Duiba, a Chinese enterprise services company that specializes in marketing and user engagement programs.
PE-backed Sunlands completes $149m US IPO
Private equity-backed Sunlands Online Education ended its first day of trading on the New York Stock Exchange marginally below its IPO price following a $149.5 million offering.
Orchid leads $65m round for Chinese wedding platform
Hunliji, a China-based online wedding services provider, has raised $65 million in a Series C round of funding led by Orchid Asia Group.
Tencent, Orchid Asia back China music learning platform
VIP Peilian, a Chinese online music tutoring platform, has completed a Series B round of funding led by Tencent Holdings and Orchid Asia.
Orchid raises $1.3b for Fund VII – update
Orchid Asia has closed its seventh fund at $1.3 billion. The vehicle had initially targeted a final close of $900 million by November 2017.
Orchid targets $900m for Fund VII, PSERS re-ups
Orchid Asia is targeting $900 million for its seventh fund and has won a $75 million commitment from Pennsylvania Public School Employees’ Retirement System (PSERS). It expects to do a first and final close in November.
China agricultural services platform secures $29m round
Orchid Asia Group and China Growth Capital have jointly led a RMB200 million ($29 million) Series B round for Dafengshou, a Shenzhen-based agricultural supply chain service online platform. Existing investor Matrix Partners also participated.
CVC backs $1.1b Nirvana Asia take-private
CVC Capital Partners has offered to buy out Hong Kong-listed Nirvana Asia, Asia’s largest funeral services firm, in a cash and stock swap deal worth $1.1 billion.
Orchid Asia, Eastern Bell in Series B for China’s Weimeizi
Orchid Asia Group and Eastern Bell Ventures have provided a Series B round of funding for Weimeizi, a Chinese personal care products manufacturer.
Zhejiang Century Huatong to buy China PE-backed gaming assets
Shenzhen-listed Zhejiang Century Huatong Group will acquire game developers China Mobile Games & Entertainment Group (CMGE) and DianDian Interactive for a combined RMB13.5 billion ($2.1 billion), facilitating exits for several PE investors.